… the levels of 87 circulating cytokines sampled from plasma in healthy controls to patients …
Our secondary objective was to determine whether any of the differentially expressed cytokines …

… meaningful variables, including proteins and cytokines in fluids such as blood or bronchoalveolar
lavage (BAL), or genetic mutations and polymorphisms. An ideal biomarker should be …

… Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease of unknown origin. IPF has a dismal
… The L412F polymorphism of TLR3 leads to altered cytokine production and dysregulated …

… more activation in pulmonary tissue remodeling and pulmonary fibrosis and less … cytokine
TGF-β 1 as a genetic modifier in patients with CF. We showed that genetic polymorphisms …

… It is getting more and more clear that genetic polymorphisms, whole blood transcriptomic
profile, as well as lung microbiome are predicting groups of diverse disease behaviour and …

… to test the association between gene polymorphisms and the … of the gene polymorphisms
on the outcomes of patients up to … nucleotide polymorphism (SNP) (rs 2070874) on patient …

… , may also exhibit a progressive fibrotic pattern (Case 2022). In this study, we will focus on
ILDs related to the phenotype of progressive pulmonary fibrosis, especially IPF, rheumatoid …

… to idiopathic pulmonary fibrosis (IPF). However, it was still unclear whether there were casual
associations between circulating inflammatory cytokines and … of circulating cytokines were …

… One of the novelties of this review is giving an extensive description of the multiple roles of
cytokine and growth factor pathways in pulmonary fibrosis, which provide new insights into …

… Pulmonary emphysema and idiopathic pulmonary fibrosis (IPF) are two distinctive diseases
… most potent fibrogenic cytokine, is essential in the progression of pulmonary fibrosis. TGF-β …